About us.
Find out how we’re transforming ideas into impact at scale through the businesses we identify, back and grow.
Our portfolio.
Investors.
We have a proven track-record in backing and nurturing science and technology-based businesses to deliver a better future for people and planet.
Our impact.
Find out how we’re living our purpose and identifying, backing and growing businesses that contribute to a healthier, tech-enriched, sustainable future.
News & Events.
Open and close mobile menu
Mach42 completes £7m funding round, led by IP Group with investment from BGF and Foresight Group
Mission Therapeutics Limited
Mission Therapeutics strikes deal worth up to $292m for Dimerix Ltd to develop Acute Kidney Injury asset MTX652
Oxford Nanopore Technologies Plc
Oxford Nanopore Technologies plc - Half year trading update and notice of results
Istesso Ltd
Istesso initiates Phase 2 clinical trial of leramistat in sarcopenia
Hysata
Hysata celebrates five years of growth and diversity with its first electrolyser order
Mantle8
France doubles down on natural hydrogen as Mantle8 secures exclusive Pyrenees permit
Pfizer obesity royalty interest
Robust Phase 2b efficacy and favorable tolerability support monthly dosing for Pfizer’s GLP-1 RA Berobenatide
Oxford Quantum Circuits Limited
OQC raises £260m in Europe’s largest ever private quantum computing funding round
Genomics
Genomics launches the Mystra AI platform, adopted by industry giants and up-and-coming biotechs
Audioscenic Ltd
Audioscenic™ to showcase next-generation spatial audio platform at COMPUTEX Taipei 2026
News & Events
Events
